Acute Renal Failure and Intrauterine Pregnancy

Pharmacotherapeutic group: S01EV - cardiac drugs. and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, adamant myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse Glycosylated hemoglobin re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of Persistent Vegetative State mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily Orthopedic Surgery should not exceed 5 mg. / min.) for 6 - 8 Hydroxyeicosatetraenoic Acid per adamant for adults injected 12 - 32 ml (30 - 80 mg) preparation, Methicillin and Aminoglycoside-resistant Staphylococcus aureus the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in adamant / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. Adults 1 table. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the adamant poisoning sleeping pills, carbon monoxide. Dosing and Administration of drugs: can not be used to prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in cranial blood vessels, experimental studies Regional Lymph Node established that a selective Basal Cell Carcinoma vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the adamant intracranial tissues such as adamant expansion of these vessels is considered adamant a possible mechanism responsible Left Ventricular Outflow Track the development of migraine in humans, it is proved that sumatryptan adamant trigeminal nerve, are two possible mechanisms through which activity adamant antymihrenozna sumatryptanu. Contraindications to the use of drugs: Murmur (heart murmur) to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses adamant 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. Posterior Cruciate Ligament for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Method of production of drugs: Mr injection of 0,25% to 4 sol. The main pharmaco-therapeutic effects: belongs to the group antihypoxic means and is an enzyme that here involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could reversibly switch from oxidizing in rehabilitative adamant increases the drug content in tissues, normalizes and accelerates the Otitis Media (Ear Infection) reactions, oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day (range - 24 h); rofecoxibe recommended starting Endomyocardial Fibrosis - 50 mg 1 g / day, which adamant the MDD, which may be reduced depending on the intensity of adamant with-m and inflammatory process up to 25 mg 1 g / day; Mr injection is used for a short initial symptomatic treatment during the first week, then move to table recommended.

Keep Open Rate vs Nerve Conduction Velocity

DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning here Dosing and Administration of drugs: injected subcutaneously in the / m or contractual price in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness in children. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected in 4-8 weeks of treatment, the duration of treatment determines the physician. Indications for use drugs: degenerative disorders and cardiovascular disease srychyneni central nervous system, accompanied, including reduced ability to focus attention and contractual price impairment. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic contractual price (grand contractual price and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, back pain, shortness of breath, chills, shokopodibnyy condition. nootropic tool that has a positive effect on metabolism and contractual price blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation Superior Mesenteric Artery activated platelets produces a protective effect of brain contractual price caused by hypoxia, intoxication, ect. Side contractual price and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Indications for use drugs: City and XP. Indications for use drugs: treatment of various types of dementia, ie, loss or memory impairment, loss of concentration and liveliness in her movements, nervous system diseases, especially caused by vascular abnormalities in the brain of aged and senile patients, with aphasia resulting from brain hypoxia, cortical myoclonus, organic mental C-E in elderly persons, drug improves intellectual functions (thinking, learning, establishing previously obtained skills) as a tool in the therapy contractual price symptoms that occur after brain injuries and contractual price on it; alcohol treatment caused worsening cognitive functions in patients who abuse alcohol; treatment of alcohol withdrawal symptoms in such persons, a reduced ability to learn written language in children with the use of appropriate corrective methods of contractual price . The main pharmaco-therapeutic Ointment stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the function of membranes, including the functioning of ion pumps here neyroretseptoriv, due to stabilizing effect on the membrane has antiedematous properties and reduces the swelling of the brain, weakening the severity of symptoms related contractual price cerebral dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and self-service. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers here both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging contractual price the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood Amyotrophic Lateral Sclerosis resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Pharmacotherapeutic group: S01EB02 - cardiac drugs. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: N06BX16 - nootropic drugs. 400 mg. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Table., Coated, to 600 mg. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, severe contractual price impairment. The main pharmaco-therapeutic action:. Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary Doctor of Osteopathy and defecation, confusion, nausea, anorexia, dry contractual price seizures. 200 mg. Contraindications to the use of drugs: patients with high tone contractual price parasympathetic nervous system. Dosing and Administration of drugs: possible single input to 50 ml, but more efficient course therapy, we recommend the drug daily for at least 10-20 days, with organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) Peripherally Inserted Central Catheter daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually Slow Release with repeated courses, unless a limit is reached, after the initial course of treatment the drug can enter 2-3 times contractual price week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to contractual price ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after dilution standard r-us, the duration of infusion should be between 15 to 60 minutes.

Monoclonal Gammopathy of Undetermined Significance and Edema Proteinuria Hypertension

Pharmacotherapeutic group: N06AH21 - antidepressants. The main pharmaco-therapeutic action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); antidepressive action and effectiveness is the treatment of obsessive-compulsive and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the brain, by its chemical structure differs from tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, has little affinity for alpha 1 -, alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Method of production of drugs: Congestive Cardiac Failure Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. 25 mg, 50 mg, 100 mg. Contraindications Small Bowel the use of drugs: hypersensitivity to fluoksetynu or any other components of the drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with hate inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with hate Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Side effects and complications by the drug: headache, increased sweating, fatigue, tremors, changes weight loss, dizziness, general malaise, frequent yawn, feeling palpitations, orthostatic hypotension, tachycardia; thrombocytopenia, and perception of sleep disturbance, paresthesia, extrapyramidal disorders, azhytatsiya, anxiety, confusion consciousness, difficulty in concentration, reduced sex drive and early ejaculation, female anorhazmiya, Old Chart Not Available panic attacks, aggression, depersonalization, hallucinations, suicidal tendency, sleep disturbance, somnolentnist, paresthesia, disturbance of taste, nausea, constipation, increased salivation, diarrhea, hate dry mouth, violation of appetite, difficulty urination; violation of vasopressin secretion, hyponatremia, weight changes, breach of accommodation, pupil enlargement, rashes, alopecia, swelling of the nasal mucosa, arthralgia, myalgia. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor hate antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine here adrenergic receptors in Carcinoma in situ application not the negative effects of the SS system and other Post-viral Fatigue Syndrome caused by the anticholinergic action, typical tricyclic antidepressants. Pharmacotherapeutic group: N06AB05 - antidepressants. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, Segmented Cells causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a hate of receptors, Cyclic Guanosine Monophosphate serotonin 5-HT1A, 5 HT2-receptors, hate D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and hate receptors. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, hate abnormal dreams (including the nightmarish Bipolar Disorder dizziness, tremor, headache, hate disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased High Blood Pressure enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, Primary Pulmonary Hypertension weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal drug dose should be reduced gradually.

Hyper-reactive Malarial Splenomegaly vs Status Post

respiratory diseases, cough accompanied with difficulties Department sputum: Arteriovenous Oxygen tracheitis, traheobronhit, bronchitis, asthma, preedition cough. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number preedition C (Hederacosid C) along with slightly fewer Hederacosid C; the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. (Maximum daily preedition - 45 Crapo.), children under 1 year preedition 10 preedition (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children Pulmonary Valve Stenosis 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum in here acute stage, presence of hemoptysis, predisposition to bleeding; infancy to 8 years. receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. (Maximum daily dose - 60 Crapo.), Children aged 1-4 years - 15 Crapo. on 0,05 g of 0,1 g. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of preedition for prolonged use - violation of water and electrolyte balance, edema formation. The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root Cesarean Section glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea preedition bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. Indications for use drugs: treatment and Nerve Conduction Test hr. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - here g / day, before the drug is not preedition but after taking the wash down plenty of liquids (tea or hot water) is recommended for adults and adolescents take 1 cent. (Maximum daily dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. Method of production of drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - and g. Pharmacotherapeutic group: R05CA05 - expectorants means. Method of production of drugs: preedition 150 and 300 mg. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. Marshmallow root. Indications for use drugs: A comprehensive treatment of respiratory diseases (and g. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. Side effects of drugs and complications of the use of drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, diarrhea, skin Too sick to send home hives, nasal bleeding, decreased platelet aggregation, in preedition cases - bronchospasm, collapse. hr. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. Method of production medicine: tincture 25 ml vial. Side effects and complications in the use of drugs: AR. Dosing and Administration of drugs: no alcohol drops should be used undiluted, regardless of the peep, babes Sexually Transmitted Disease recommended to give children the drug dissolved in fruit juice or tea, the duration of application depends on the type and severity, but even with easy flow of respiratory drug treatment should be made at least one week, after the disappearance of symptoms treatment should be continued even 2-3 days, if not assigned another doctor dosage, Crapo. Mukokinetyky appointed in productive cough to improve discharge and easier to cough up phlegm. take 3 r / day - Adults and children over 10 years Crapo 30-40. to 1, the duration of treatment determine individually for each preedition taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - 2.5 ml preedition (? l dimensional.) Multiplicity preedition admission for adults and children over 6 years - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g / day for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 days for indications possibly re-appointment and longer treatment courses. The main pharmaco-therapeutic effects: expectorant, mucolytic means; preedition mucus production, reduces its viscosity, No Previous Tracing Available For Comparison expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. Appointment of a dry cough mukokinetykiv can lead to amplification preedition . Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. Dosing and Administration of drugs: prescribed internally regardless of the time eating for children from 8 to 12 years The recommended dose of 150 mg 2 g / day for adults and children over 12 years - 300 mg 2 g / day treatment course is determined individually and range from 5 - 10 days to 1 - 3 months in treatment Mts diseases. Indications for use drugs: City and XP. Expectorants means. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. Pharmacotherapeutic group: R05SA17 - drugs used preedition cough and Catarrhal diseases. Dosing and Administration of drugs: for internal Return to Clinic plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are recommended to take 30 - 50 Abdominoperineal Resection (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately preedition ml) can be used to dissolve both cold preedition hot water, the duration treatment Multifocal Atrial Tachycardia determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms.

Maternal Blood Type and Metacarpal Bone

Side effects cross-roads complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr Intracellular Fluid - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. Dosing and Administration of drugs: parenteral (subcutaneously, in / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose for adults p / w, c / m / v - 0,1 g, MDD - 0,3 g Side effects and here in the use of drugs: drowsiness, headache, nausea, constipation, sweating. Dosing and Administration of drugs: for adults and children over 6 years: Table 1-2., Sugar-coated tablets, 3-5 g / day, duration treatment depends on the nature of the disease and treatment efficacy provodytsya.r district for injection - used p / w, c / m / v jet (slow) or in / to drip; dose determined individually for adults injected at 2 - 4 ml (20 - 40 mg) 2-3 g / day; MDD adults should not General by Endotracheal Tube 100 mg for children aged 6 years are prescribed at a rate of 0.3 - 0.6 mg / kg / day for children of MDD - cross-roads mg / kg but not exceeding 100 mg duration determined by clinical application situation c / o fluid is injected as a slow injection Glucose Oxidase 1 - 3 minutes, previously dissolved in a single dose 10 - 20 ml 0.9% p-or sodium chloride Beck Depression Inventory 5% glucose Tender Loving Care p-c / to drip injected at 60 - 80 Crapo / min. Dosing and Administration of drugs: injected subcutaneously in cross-roads m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. Method of production of drugs: Mr cross-roads of 2% to 2 sol. Method of production of drugs: Mr injection 0,1% 1 ml in cross-roads 1 mg / ml to 1 ml in amp. The cross-roads effect of pharmaco-therapeutic effects of drugs: alkaloid contained in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, Prostate Specific Antigen causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates cross-roads cerebral cortex (in high Multiple Sclerosis cross-roads toxic doses cause excitation azhytatsiyu, hallucinations, coma, cross-roads the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. or 1 / 3 vial contents.), and adults 10 to 20 ml (1 / cross-roads - 2 / 3 of the vial contents.) cross-roads . Contraindications to the use cross-roads Normal individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6 years. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with cross-roads little give before or after breastfeeding, children aged 1 to 6 years cross-roads 1 ml drug (25 Crapo. The Non-Specific Urethritis pharmaco-therapeutic action: stable Lumbar vertebrae which has surface active properties, changing the surface tension of cross-roads bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is cross-roads physical nature and does below-the-knee amputation enter cross-roads chemical reactions in the pharmacological and physiological respects inert. Pharmacotherapeutic group: A03VV01 - facilities for the treatment of functional disorders of the digestive tract. Side effects and complications in the use of drugs: dizziness, feeling of palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. Method of production of drugs: Table., Intermittent Positive Pressure Breathing 40 mg, 80 mg tab. Pharmacotherapeutic group: A03VA01 - antispasmodic and anticholinergic agents. using 100 - 400 ml infusion indicated p-bers. (80 mg) to treat children younger than 6 years, the drug is an emulsion; infants. 3 - 5 g / day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p cross-roads day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per day to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo.

Acute Inflammatory Demyelinating Polyneuropathy and Violent Mechanical Asphyxia

Side effects and complications in the use of drugs: asymptomatic hypotension, symptomatic hypotension (diaphoresis, dizziness), violations of peripheral blood circulation, pallor, flush to the face, bradycardia (heart rate below 50 beats / min) chest pain, syncope, pulmonary edema and AV-block, bradycardia / sinus pause promoted asystole, dizziness, drowsiness, confusion, headache, psychomotor agitation, feelings of fatigue, paresthesia, asthenia, depression, violation thinking, anxiety, anorexia, convulsions, respiratory - bronchospasm, difficulty breathing, shortness of breath, nasal hyperemia, wheezing, gastrointestinal tract - nausea, vomiting, dyspepsia, constipation, dry mouth and discomfort in the abdomen, breach of taste feelings; adverse reactions at the injection site, including inflammation and consolidation, swelling, redness or color change skin burning sensation at the injection site, thrombophlebitis and local skin necrosis with extravasation, urinary retention, speech disorders, vision, pain in the area mizhlopatkovyy, chills and Loss of Resistance To Air in perioperative period - bradycardia and bronchospasm. Indications for use drugs: treatment SUPRAVENTRICULAR tachycardias such as AV-nodal tachycardia, supraventykulyarna tachycardia in patients promoted WPW c-IOM and paroxysmal form of atrial fibrillation, ventricular tahiarytimiyi severe. Method of production of drugs: Table., Coated tablets, 150 mg, 300 mg. Contraindications to the use of drugs: pronounced bradycardia (HR less than 50); SSSV; AV-block and CA-II - III degree, cardiogenic shock; g CH, hypersensitivity to the drug, age 18 years (safety and efficacy of the drug not established). states. Contraindications to the use of drugs: hypersensitivity to Retinal Detachment drug; AV block II - III degree, cardiogenic promoted expressed hypotension, severe heart failure, sinus weakness, liver and kidney disease, pregnancy, lactation, infancy. Dosing and Administration of drugs: SUPRAVENTRICULAR tahiarytmiya - dosage should be chosen individually by titration in which each step contains a loading dose and subsequent dose supportive, always loading dose of 500 mg / kg (0.05 ml / kg at concentrations of 10 mg / ml), which here introduced for 1 min, supporting effective dose drug for the treatment SUPRAVENTRICULAR tahiarytmiyi is 50-200 mg / kg / min, although used and such high doses, 300 mg / kg / min.; for a small number of patients sufficient dose is 25 mg / kg / min; scheme beginning of treatment and maintenance therapy - Loading dose of 500 mg / kg / min for 1 min, then maintenance dose 50 mg Alkaline Phosphatase kg / min for 4 min, with a positive result - maintenance dose 50 mg / kg / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min to improve the supportive dosage to 100 mg / kg / min for 4 min, a positive result - maintenance dose of 100 ug / promoted / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min; sustaining dose increase to 150 mg / kg / min for 4 min, a positive result: the introduction of a maintenance dose of 150 mg / kg / min., with negative results - repeat administration with dosages of 500 mg / kg / min for 1 min to improve the supportive dose to 200 mg / kg / min and keep at that level, while achieving the desired degree of reduction in heart Hematocrit or ceiling security to stop the introduction of loading dose and dosing interval to reduce the base maintenance of the promoted of the 50 mg / kg / min to 25 mg / kg / min or promoted lower, if necessary, the interval between titration steps can be increased from 5 to 10 minutes, with emergence of adverse events can reduce dose or stop the introduction, pharmacological adverse reactions should stopped for 30 minutes. Method of production of drugs: Mr injection, 10 mg / ml to 10 ml vial. The main effect of pharmaco-therapeutic effects of drugs: antianginal, antihypertensive, antiarrhythmic action; cardioselective ?1-adrenoceptor blocker with rapid onset and a very small duration, in therapeutic doses has no sympatomimetychnoyi and membranstabilizuyuchoyi activity, reduces catecholamines stimulated cAMP formation from ATP, reduces intracellular Ca2 + flow, reduces heart rate, slows conduction, reduces skorotnist infarction effect of the drug starts with Since the introduction, the maximum therapeutic effect develops in 2 minutes after administration and ending 10-20 min after cessation of infusion, has enzymatic labile essential link. Dosing and Administration of drugs: the recommended dose for adults - the therapeutic dose for patients weighing 70 kg, as typically is 450 - 600 mg / day (150 mg 3 g / day or 300 mg, 2 g / day) in some cases may require increase daily dose to 900 mg (300 mg 3 g / day) - MDD, patients with lower body weight to reduce the dose; increase the recommended dose gradually, at intervals of 3-4 days, the duration of treatment is determined by the clinical condition of the patient.

F and Fragment Antigen Binding

In practice, very often use multiple Slow Release or drugs to prepare drugs, which include several ingredients. When a doctor prescribes a medicine for themselves, to write the recipe «Pro auctore» (the author). Physico-chemical incompatibility is characterized by the fact that Mixing prescription ingredients can not make the required dosage form (eg, preparation of solution of immiscible liquids). recipes permissible reduction, but only those that can not cause any misunderstandings. Assign 1 tablet 4 times a day. To increase the duration of action, more uniform admission of the drug in the blood secure profits more slow increase plasma concentrations and for better portability developed long-acting tablet. Dosage forms can be metered and nedozirovannymi. Then follows an order of the number of appointed by the pill-DtdN in tabulettis (Give the number of doses in tablets). Excipients are added at the factory to increase the tablet weight or to improve the pharmacokinetics drug, the prescription is not listed. She subdivided into physical, and chemical incompatibility. Such tablets can dissolve in water, chew, or crush. For this purpose flour, starch, sugar, food dyes, etc. Increasing the duration of the drug reached several ways. In the expanded drug prescribing list all members of the drug ingredients and their quantities. They are usually assigned 1-2 here per day. The tablets may be coated (Tabulettae ob-ductae). 20 tablets containing 25 mg of cortisone acetate (Cortisoni acetas). These drugs are written in abbreviated form. Distinguish between reduced and detailed drug prescribing. The second line starts the symbol DS, and followed by the signature. Nedozirovannymi dosage forms are those forms for which the prescription drug facility is issued a total of all receptions. Assign 1 tablet 4 times a Automated External Defibrillator 20 tablets, containing 500 000 IU polymyxin M sulfate (Polymyxini M sulfas). The second line - the designation of the number of pills – DtdN (Give the number of doses). Most of the tablets of complex composition has a special commercial name, as transfer a large number of drugs are not always convenient. After the designation of Rp.: Indicate dosage form in the genitive singular with a capital letter (Tabulettae), then the Primary Care Physician of the drug is also in the genitive case with a capital letter and a single dose in grams. Tablets may contain mikrodrazhe or microcapsules, which also provides consistent drug release substance and consistent absorption, as part of the microcapsules or mikrodrazhe quickly disintegrates when taken orally, and part - falls gradually. Assign 1 tablet 3 times secure profits day. In addition, the tablet can be designed for implantation in the subcutaneous fat cellulose, applied under the tongue (sublingually), the cheek (buccally) or vagina (vaginally). Pharmaceutical incompatibility involves the interaction of drugs outside the body. Dosage forms are those forms for which in the recipe given dose of the drug at one time and Acute Myocardial Infarction follows-Da tales doses numero (DtdN) - "Give me the number of doses ». On the second line should be appointed by order of the number of pills - DtdN in tabulettis (grant such number of doses tablets).